Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Anaprazole - Sihuan Pharmaceutical Holdings Group

X
Drug Profile

Anaprazole - Sihuan Pharmaceutical Holdings Group

Alternative Names: Anaprazole sodium - Sihuan; KBP-3571

Latest Information Update: 22 Mar 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sihuan Pharmaceutical Holdings Group
  • Class Antiulcers
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preregistration Duodenal ulcer

Most Recent Events

  • 09 Mar 2023 Sihuan Pharmaceutical Holdings Group completes a phase III trial for Duodenal ulcer in China (PO) (NCT04215653)
  • 09 Nov 2022 Xuanzhu Biopharmaceutical plans a phase II trial of Anaprazole in reflux Oesophagitis, In China (PO, Tablet), In December 2022 (NCT05604261)
  • 08 Mar 2022 Preregistration for Duodenal ulcer in China (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top